ATE274507T1 - Benzofuran- und benzothiophen-derivative als selektive cox-2 inhibitoren - Google Patents
Benzofuran- und benzothiophen-derivative als selektive cox-2 inhibitorenInfo
- Publication number
- ATE274507T1 ATE274507T1 AT01994723T AT01994723T ATE274507T1 AT E274507 T1 ATE274507 T1 AT E274507T1 AT 01994723 T AT01994723 T AT 01994723T AT 01994723 T AT01994723 T AT 01994723T AT E274507 T1 ATE274507 T1 AT E274507T1
- Authority
- AT
- Austria
- Prior art keywords
- benzofuran
- inhibitors
- selective cox
- benzothiophene derivatives
- benzothiophene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25128300P | 2000-12-05 | 2000-12-05 | |
PCT/EP2001/013716 WO2002046178A2 (en) | 2000-12-05 | 2001-11-26 | Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE274507T1 true ATE274507T1 (de) | 2004-09-15 |
Family
ID=22951260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01994723T ATE274507T1 (de) | 2000-12-05 | 2001-11-26 | Benzofuran- und benzothiophen-derivative als selektive cox-2 inhibitoren |
Country Status (16)
Country | Link |
---|---|
US (1) | US6433005B1 (de) |
EP (1) | EP1347963B1 (de) |
JP (1) | JP4212892B2 (de) |
KR (1) | KR20030070054A (de) |
CN (1) | CN1273460C (de) |
AR (1) | AR035719A1 (de) |
AT (1) | ATE274507T1 (de) |
AU (2) | AU2002224890B2 (de) |
BR (1) | BR0115963A (de) |
CA (1) | CA2437048A1 (de) |
DE (1) | DE60105195T2 (de) |
ES (1) | ES2225641T3 (de) |
MX (1) | MXPA03004398A (de) |
PT (1) | PT1347963E (de) |
WO (1) | WO2002046178A2 (de) |
ZA (1) | ZA200303641B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020009383A (ko) * | 1998-04-01 | 2002-02-01 | 우에노 도시오 | 축합 티오펜 유도체 및 이의 유도체를 유효 성분으로 하는약제 |
JP2001261674A (ja) * | 2000-03-22 | 2001-09-26 | Mitsui Chemicals Inc | ベンゾチオフェン誘導体およびそれを有効成分として含有する核内レセプター作動薬 |
AU5878001A (en) * | 2000-05-18 | 2001-11-26 | Daiichi Pharmaceutical Co., Ltd. | Novel benzothiophene derivatives |
WO2002000641A2 (en) * | 2000-06-28 | 2002-01-03 | Eli Lilly And Company | Spla2 inhibitors |
US7071220B2 (en) * | 2000-09-18 | 2006-07-04 | Toa Eiyo Ltd. | N-substituted benzothiophenesulfonamide derivatives |
WO2005033112A2 (en) * | 2003-10-02 | 2005-04-14 | Cephalon, Inc. | Substituted indole derivatives |
EP1984333B1 (de) | 2006-02-03 | 2012-04-25 | Bionomics Limited | Substituierte benzofurane, benzothiophene, benzoselenophene und indole und ihre verwendung als tubulinpolymerisationsinhibitoren |
JP2010509259A (ja) | 2006-11-09 | 2010-03-25 | エフ.ホフマン−ラ ロシュ アーゲー | インドール及びベンゾフラン2−カルボキサミド誘導体 |
AU2011202542A1 (en) | 2010-07-14 | 2012-02-02 | Indian Institute Of Science | Benzothiophene carboxamide compounds, composition and applications thereof |
CN103819371B (zh) * | 2012-11-16 | 2016-05-04 | 中国科学院大连化学物理研究所 | 一种对甲砜基苯甲醛的合成方法 |
CN103058988B (zh) * | 2012-12-31 | 2015-09-02 | 中国人民大学 | 苯并噻吩及其衍生物及其制备方法与应用 |
CN110903225B (zh) * | 2019-12-11 | 2021-11-09 | 苏州开元民生科技股份有限公司 | 一种对甲砜基苯甲醛的合成方法 |
KR102542698B1 (ko) * | 2022-04-05 | 2023-06-14 | 주식회사 베노바이오 | 신규한 벤조사이오펜 유도체 및 bet 억제제로서의 용도 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3331854A (en) * | 1964-12-14 | 1967-07-18 | American Cyanamid Co | Novel furan and thiophene compounds |
US4933351A (en) | 1983-10-31 | 1990-06-12 | Merck Frosst Canada, Inc. | Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis |
US4663347A (en) | 1983-10-31 | 1987-05-05 | Merck Frosst Canada, Inc. | Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis |
US4822803A (en) | 1983-10-31 | 1989-04-18 | Merck Frosst Canada, Inc. | Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis |
US4745127A (en) * | 1983-10-31 | 1988-05-17 | Merck Frosst Canada, Inc. | Benzyl esters of benzofuran-2-carboxylic acids useful as inhibitors of leukotriene biosynthesis |
DE3342624A1 (de) | 1983-11-25 | 1984-03-29 | Heinfried Dr. 4019 Monheim Grote | Benzaronderivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel |
US4621091A (en) | 1984-10-09 | 1986-11-04 | Merck & Co., Inc. | 3-hydroxybenzo[b]thiophene-2-sulfide derivatives compositions, and method of use therefor |
US5208253A (en) * | 1992-02-24 | 1993-05-04 | Warner-Lambert Company | 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo(b) thiophene-2-carboxamides as inhibitors of cell adhesion |
EP0789569A2 (de) | 1993-07-15 | 1997-08-20 | Warner-Lambert Company | Verwendung von benzothiophenen und benzofuranen zur behandlung der entzündlichenerkrankungen des darmes und entzündungs testverfahren |
US5426113A (en) | 1994-04-08 | 1995-06-20 | Warner-Lambert Company | Method of preventing ulcer formation caused by nonsteroidal antiinflammatory drugs employing tetrazol-benzothiophene carboxamide compounds |
US5521213A (en) * | 1994-08-29 | 1996-05-28 | Merck Frosst Canada, Inc. | Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
ATE204869T1 (de) * | 1996-02-22 | 2001-09-15 | Lilly Co Eli | Benzothiophene, selbige enthaltende zusammensetzungen und verfahren zu deren herstellung |
US5731342A (en) | 1996-02-22 | 1998-03-24 | Eli Lilly And Company | Benzothiophenes, formulations containing same, and methods |
-
2001
- 2001-11-26 KR KR10-2003-7007600A patent/KR20030070054A/ko active IP Right Grant
- 2001-11-26 MX MXPA03004398A patent/MXPA03004398A/es active IP Right Grant
- 2001-11-26 BR BR0115963-1A patent/BR0115963A/pt not_active IP Right Cessation
- 2001-11-26 AT AT01994723T patent/ATE274507T1/de not_active IP Right Cessation
- 2001-11-26 CA CA002437048A patent/CA2437048A1/en not_active Abandoned
- 2001-11-26 AU AU2002224890A patent/AU2002224890B2/en not_active Ceased
- 2001-11-26 AU AU2489002A patent/AU2489002A/xx active Pending
- 2001-11-26 WO PCT/EP2001/013716 patent/WO2002046178A2/en active IP Right Grant
- 2001-11-26 ES ES01994723T patent/ES2225641T3/es not_active Expired - Lifetime
- 2001-11-26 EP EP01994723A patent/EP1347963B1/de not_active Expired - Lifetime
- 2001-11-26 PT PT01994723T patent/PT1347963E/pt unknown
- 2001-11-26 CN CNB01820077XA patent/CN1273460C/zh not_active Expired - Fee Related
- 2001-11-26 DE DE60105195T patent/DE60105195T2/de not_active Expired - Fee Related
- 2001-11-26 JP JP2002547917A patent/JP4212892B2/ja not_active Expired - Fee Related
- 2001-12-03 AR ARP010105603A patent/AR035719A1/es not_active Application Discontinuation
- 2001-12-03 US US10/006,349 patent/US6433005B1/en not_active Expired - Fee Related
-
2003
- 2003-05-12 ZA ZA200303641A patent/ZA200303641B/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT1347963E (pt) | 2004-12-31 |
AR035719A1 (es) | 2004-07-07 |
ES2225641T3 (es) | 2005-03-16 |
JP4212892B2 (ja) | 2009-01-21 |
ZA200303641B (en) | 2004-08-12 |
KR20030070054A (ko) | 2003-08-27 |
JP2004517088A (ja) | 2004-06-10 |
DE60105195T2 (de) | 2005-09-08 |
EP1347963B1 (de) | 2004-08-25 |
CA2437048A1 (en) | 2002-06-13 |
EP1347963A2 (de) | 2003-10-01 |
US6433005B1 (en) | 2002-08-13 |
AU2002224890B2 (en) | 2007-03-22 |
WO2002046178A2 (en) | 2002-06-13 |
CN1479736A (zh) | 2004-03-03 |
DE60105195D1 (de) | 2004-09-30 |
CN1273460C (zh) | 2006-09-06 |
WO2002046178A3 (en) | 2002-10-10 |
US20020107280A1 (en) | 2002-08-08 |
BR0115963A (pt) | 2003-10-28 |
AU2489002A (en) | 2002-06-18 |
MXPA03004398A (es) | 2003-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE437862T1 (de) | Pyrimidin-5-onderivate als ldl-pla2 inhibitoren | |
DE69919887D1 (de) | Pyrazolopyridin derivative als selektive cox-2 inhibitoren | |
ATE323072T1 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
ATE256127T1 (de) | Betacarbolinderivate als phosphodiesterase- inhibitoren | |
AR028567A1 (es) | Nuevos derivados de fenil-propargileter | |
DE60136571D1 (de) | Guanidinobenzamide als mc4-r agonisten | |
AR028596A1 (es) | Nuevos derivados de fenilglicina | |
ATE278690T1 (de) | Substituierte pyprolopyridinonderivate als phosphodiesterase-inhibitoren | |
DE69906311D1 (de) | Diarylbenzopyranderivate als cyclooxygenase-2-inhibitoren | |
FR2818646B1 (fr) | Nouveaux derives c-glycoside et utilisation | |
ATE298332T1 (de) | Decahydro-isochinolinderivate | |
DE60118569D1 (de) | 4-phenylpyridin-derivate als neurokinin-1-rezeptor-antagonisten | |
ATE274507T1 (de) | Benzofuran- und benzothiophen-derivative als selektive cox-2 inhibitoren | |
DE60203529D1 (de) | Indolderivate als cox-ii-inhibitoren | |
ATE428420T1 (de) | Substituierte 8-arylchinoline als phosphodiesterase-4-hemmer | |
NO20031386L (no) | Substituerte C-cykloheksylmetylaminderivater | |
ATE370944T1 (de) | Chromenon- und chromanonderivate als integrinhemmer | |
DE60005980D1 (de) | Benzopyran und benzothiopyran, verwendbar als selektive retinoid-agonisten | |
ATE272045T1 (de) | Substituierte 1-aminobutan-3-ol-derivate | |
PT1351959E (pt) | Novos derivados de pleuromutilina | |
PT1339695E (pt) | Inibidores da farnesiltransferase | |
NO20025475L (no) | Nye benzotiofenderivater | |
NO20025474D0 (no) | Benzofuranderivater | |
DE60118941D1 (de) | Pyrrolidin-2-carbonsäure-hydrazid-derivate als metalloprotease-inhibitoren | |
DE60117096D1 (de) | Dihydroindol- und tetrahydrochinolinderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1347963 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |